In this group there is probably a remarkable neo-antigens production with an equally remarkable T-cell immuno-mediated response counterbalanced by checkpoint inhibitor signaling, e.g. PD-L1, on both IICs and NCs, that would guarantee tumor tolerance and favor tumor progression. This evidence concerns the gene CD274 and neoplasm.